Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Marko Spanjol"'
Autor:
Reto Kaderli, Piotr Radojewski, Cédric Nesti, Viktoria Gloy, Rebecca A. Dumont, Matthias Briel, Lukas Bütikofer, Marko Spanjol, Attila Kollár, Christian Seiler, Martin A. Walter, Emanuel Christ
Publikováno v:
Cochrane Database Syst Rev
Walter, Martin A; Nesti, C; Spanjol, Marko; Kollár, A; Bütikofer, L; Gloy, Viktoria L; Dumont, Rebecca A; Seiler, Christian A; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Kaderli, Reto M (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane database of systematic reviews, 11(11), CD013700. WileyInterscience 10.1002/14651858.CD013700.pub2
Walter, Martin A; Nesti, C; Spanjol, Marko; Kollár, A; Bütikofer, L; Gloy, Viktoria L; Dumont, Rebecca A; Seiler, Christian A; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Kaderli, Reto M (2021). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis. Cochrane database of systematic reviews, 11(11), CD013700. WileyInterscience 10.1002/14651858.CD013700.pub2
BACKGROUND Several available therapies for neuroendocrine tumours (NETs) have demonstrated efficacy in randomised controlled trials.��However, translation of these results into improved care faces several challenges, as a direct comparison of the
Autor:
Martin A Walter, Marko Spanjol, Attila Kollár, Lukas Bütikofer, Viktoria L Gloy, Rebecca A Dumont, Christian A Seiler, Emanuel R Christ, Piotr Radojewski, Matthias Briel, Reto M Kaderli
Publikováno v:
Walter, Martin A; Spanjol, Marko; Kollár, Attila; Bütikofer, Lukas; Gloy, Viktoria L; Dumont, Rebecca A; Seiler, Christian A.; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Kaderli, Reto M (2020). Treatment for gastrointestinal and pancreatic neuroendocrine tumours: a network meta-analysis [protocol]. Cochrane database of systematic reviews, 8, CD013700. WileyInterscience 10.1002/14651858.CD013700
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::20c33e27162726649ed9c50e0025c6da
https://boris.unibe.ch/150240/1/Walter_et_al-2020-Cochrane_Database_of_Systematic_Reviews.pdf
https://boris.unibe.ch/150240/1/Walter_et_al-2020-Cochrane_Database_of_Systematic_Reviews.pdf
Autor:
Christian Kreis, Petar Marko Spanjol, Andrea Daniela Maier, Morten Ziebell, Ian Law, Lars Poulsgaard, Tina Nørgaard Munch, Martjin van Essen, Daniela A. Bota, Thomas Graillon, Asma Bashir, Christian Mirian, Lasse Rehné Jensen, Helle Broholm, Kåre Fugleholm, Maria Pedersen, Martin A. Walter, Anne Katrine Duun-Henriksen, Maya Hrachova, Tiit Mathiesen
Publikováno v:
Mirian, C, Duun-Henriksen, A K, Maier, A, Pedersen, M M, Jensen, L R, Bashir, A, Graillon, T, Hrachova, M, Bota, D, van Essen, M, Spanjol, P, Kreis, C, Law, I, Broholm, H, Poulsgaard, L, Fugleholm, K, Ziebell, M, Munch, T, Walter, M A & Mathiesen, T 2021, ' Somatostatin Receptor-Targeted Radiopeptide Therapy in Treatment-Refractory Meningioma : Individual Patient Data Meta-analysis ', Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 62, no. 4, pp. 507-513 . https://doi.org/10.2967/jnumed.120.249607
Somatostatin receptor (SSTR)-targeted peptide receptor radionuclide therapy (PRRT) represents a promising approach for treatment-refractory meningiomas. Methods: We performed an individual patient data meta-analysis, including all published data on m
Autor:
Christian Seiler, Matthias Briel, Piotr Radojewski, Emanuel Christ, Attila Kollár, Martin A. Walter, Marko Spanjol, Reto Kaderli, Viktoria Gloy, Lukas Bütikofer, Rebecca A. Dumont
Publikováno v:
Kaderli, Reto Martin; Spanjol, Marko; Kollár, Attila; Bütikofer, Lukas; Gloy, Viktoria; Dumont, Rebecca A; Seiler, Christian A.; Christ, Emanuel R; Radojewski, Piotr; Briel, Matthias; Walter, Martin A (2019). Therapeutic Options for Neuroendocrine Tumors: A Systematic Review and Network Meta-analysis. JAMA oncology, 5(4), pp. 480-489. American Medical Association 10.1001/jamaoncol.2018.6720
JAMA Oncology (2019)
JAMA Oncology (2019)
Importance Multiple therapies are currently available for patients with neuroendocrine tumors (NETs), yet many therapies have not been compared head-to-head within randomized clinical trials (RCTs). Objective To assess the relative safety and efficac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5667309b9823773778088913dcddeabb
https://europepmc.org/articles/PMC6459123/
https://europepmc.org/articles/PMC6459123/
Autor:
Maria Umlauft, Piotr Radojewski, Jan Beyersmann, Attila Kollár, Martin A. Walter, Nicolas Marincek, Rebecca A. Dumont, Philippe Brunner, Petar-Marko Spanjol, Jan Mueller-Brand, Markus Laimer, Helmut R. Maecke
Publikováno v:
Journal of Nuclear Medicine. 58:97-102
We aimed to assess the risk of developing diabetes mellitus and its effects on all-cause mortality after radiopeptide therapy for neuroendocrine tumors (NET). Methods: NET patients received somatostatin radiopeptide therapy with yttrium-90-DOTATOC an
Autor:
Ann-Catherine Jörg, Philippe Brunner, Anja Schmitt, Helmut R. Maecke, Aurel Perren, Nicolas Marincek, Rebecca A. Dumont, Petar Marko Spanjol, Katharina Glatz, Matthias Briel, Piotr Radojewski, Lukas Bubendorf, Jan Müller-Brand, Martin A. Walter, Thomas Krause, Maria Umlauft
Publikováno v:
Brunner, Philippe; Jörg, Ann-Catherine; Glatz, Katharina; Bubendorf, Lukas; Radojewski, Piotr; Umlauft, Maria; Marincek, Nicolas; Spanjol, Petar Marko; Krause, Thomas Michael; Dumont, Rebecca A; Maecke, Helmut R; Müller-Brand, Jan; Briel, Matthias; Schmitt, Anja; Perren, Aurel; Walter, Martin Alexander (2017). The prognostic and predictive value of sstr2-immunohistochemistry and sstr2-targeted imaging in neuroendocrine tumors. European journal of nuclear medicine and molecular imaging, 44(3), pp. 468-475. Springer 10.1007/s00259-016-3486-2
PURPOSE Our aim was to assess the prognostic and predictive value of somatostatin receptor 2 (sstr2) in neuroendocrine tumors (NETs). METHODS We established a tissue microarray and imaging database from NET patients that received sstr2-targeted radio
Autor:
Thomas Krause, Bernd Klaeser, Petar Marko Spanjol, George Prenosil, Sabine Edith Weidner, Markus Fürstner, Michael Hentschel
Purpose To determine the thyroid clearance effective half-life T with a common handheld electronic dosimeter (ED) in patients undergoing radioiodine treatment for hyperthyroidism. Methods Dose rates from 12 inpatients were measured daily with an ED a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c463f956513da9afce6c07605657b2d1
Autor:
Philippe, Brunner, Ann-Catherine, Jörg, Katharina, Glatz, Lukas, Bubendorf, Piotr, Radojewski, Maria, Umlauft, Nicolas, Marincek, Petar-Marko, Spanjol, Thomas, Krause, Rebecca A, Dumont, Helmut R, Maecke, Jan, Müller-Brand, Matthias, Briel, Anja, Schmitt, Aurel, Perren, Martin A, Walter
Publikováno v:
European journal of nuclear medicine and molecular imaging. 44(3)
Our aim was to assess the prognostic and predictive value of somatostatin receptor 2 (sstrWe established a tissue microarray and imaging database from NET patients that received sstrWe included a total of 279 patients. In these patients, sstrOur resu
Autor:
Piotr Radojewski, Maria Umlauft, Markus Laimer, Helmut R. Maecke, Petar Marko Spanjol, Philippe Brunner, Jan Beyersmann, Rebecca A. Dumont, Nicolas Marincek, Jan Müller-Brand, Attila Kollár, Martin A. Walter
Publikováno v:
Journal of Nuclear Medicine. 58:1532.1-1532
REPLY: We thank Drs. Pakzad and Safiri for their interest in our paper ([1][1]). We agree that there are a variety of methodologic questions to potentially be discussed ([2][2]–[4][3]), but we disagree with their criticism of our paper. First, they
Autor:
Kaderli, Reto M., Spanjol, Marko, Kollár, Attila, Bütikofer, Lukas, Gloy, Viktoria, Dumont, Rebecca A., Seiler, Christian A., Christ, Emanuel R., Radojewski, Piotr, Briel, Matthias, Walter, Martin A.
Publikováno v:
JAMA Oncology; Apr2019, Vol. 5 Issue 4, p480-489, 10p